Insulin Efsitora versus Degludec in Type 2 Diabetes without Previous Insulin Treatment
脱胶胰岛素
胰岛素
2型糖尿病
医学
内科学
糖尿病
内分泌学
甘精胰岛素
作者
Carol Wysham,Harpreet S. Bajaj,Stefano Del Prato,Denise Reis Franco,Arihiro Kiyosue,Dominik Dahl,Chunmei Zhou,Molly C. Carr,Michael Case,Livia Firmino Gonçalves
Insulin efsitora alfa (efsitora) is a new basal insulin designed for once-weekly administration. Data on safety and efficacy have been limited to small, phase 1 or phase 2 trials.